We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+36.08%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+531.4%
AUM
$4.08B
AUM Growth
+$236M
Cap. Flow
-$708M
Cap. Flow %
-17.33%
Top 10 Hldgs %
19.32%
Holding
5,845
New
764
Increased
1,966
Reduced
2,392
Closed
665

Sector Composition

Rank Sector Weight
1 Miscellaneous 34.65%
2 Technology 23.8%
3 Financials 7.62%
4 Industrials 7.22%
5 Healthcare 6.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DNA icon
3401
Ginkgo Bioworks
DNA
$718M
$23.5K ﹤0.01%
2,367
-6,902
-74% -$57.7K
RMBI icon
3402
Richmond Mutual Bancorp
RMBI
$245M
$23.5K ﹤0.01%
1,477
-976
-40% -$14.3K
VNCE icon
3403
Vince Holding Corp
VNCE
$149M
$23.4K ﹤0.01%
3,279
-1,813
-36% -$8.35K
SHOE
3404
Shoe Station Group
SHOE
$353M
$23.4K ﹤0.01%
1,580
-355
-18% -$6.06K
ENTA icon
3405
Enanta Pharmaceuticals
ENTA
$346M
$23.4K ﹤0.01%
1,607
-3,100
-66% -$41.7K
DMRC icon
3406
Digimarc Corp
DMRC
$110M
$23.4K ﹤0.01%
2,850
+463
+19% +$4.35K
MGPI icon
3407
MGP Ingredients
MGPI
$275M
$23.4K ﹤0.01%
1,335
-161
-11% -$2.93K
CURI icon
3408
CuriosityStream
CURI
$184M
$23.4K ﹤0.01%
8,792
+2,014
+30% +$5.95K
ERO icon
3409
Ero Copper
ERO
$3.95B
$23.4K ﹤0.01%
874
+297
+51% +$8.41K
HHH icon
3410
Howard Hughes
HHH
$4.09B
$23.4K ﹤0.01%
327
+116
+55% +$7.55K
PHVS icon
3411
Pharvaris
PHVS
$2.25B
$23.4K ﹤0.01%
676
+438
+184% +$13.3K
STRT icon
3412
STRATTEC Security
STRT
$267M
$23.4K ﹤0.01%
287
-242
-46% -$18.4K
GOGO icon
3413
Gogo Inc
GOGO
$312M
$23.3K ﹤0.01%
7,532
+234
+3% +$954
OSUR icon
3414
OraSure Technologies
OSUR
$271M
$23.3K ﹤0.01%
5,233
-6,266
-54% -$22.2K
GOOD
3415
Gladstone Commercial Corp
GOOD
$605M
$23.3K ﹤0.01%
1,897
-73
-4% -$909
EBS icon
3416
Emergent Biosolutions
EBS
$348M
$23.3K ﹤0.01%
2,782
-5,360
-66% -$44.8K
IPI icon
3417
Intrepid Potash
IPI
$458M
$23.3K ﹤0.01%
711
-60
-8% -$2.28K
CD
3418
Chaince Digital Holdings
CD
$586M
$23.3K ﹤0.01%
5,329
-5,532
-51% -$32.5K
RXST icon
3419
RxSight
RXST
$194M
$23.2K ﹤0.01%
4,818
+621
+15% +$3.75K
ORMP icon
3420
Oramed Pharmaceuticals
ORMP
$197M
$23.2K ﹤0.01%
+4,827
New +$19.2K
CBK
3421
Commercial Bancgroup
CBK
$440M
$23.2K ﹤0.01%
718
-1,463
-67% -$42.8K
PACB icon
3422
Pacific Biosciences
PACB
$504M
$23.2K ﹤0.01%
13,784
-36,733
-73% -$53.4K
BVFL icon
3423
BV Financial
BVFL
$177M
$23.1K ﹤0.01%
1,092
-296
-21% -$5.92K
RCKT icon
3424
Rocket Pharmaceuticals
RCKT
$285M
$23.1K ﹤0.01%
6,758
-3,929
-37% -$13.1K
RNA
3425
Atrium Therapeutics
RNA
$142M
$23.1K ﹤0.01%
1,716
-1,044
-38% -$13.6K

Similar funds

Tower Research Capital (TRC)'s Q2 2026 Portfolio in Review

As of Q2 2026, Tower Research Capital (TRC) held 5,845 positions worth $4.08B, up 6.1% from $3.85B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Tower Research Capital (TRC) withdrew a net $708M in Q2 2026, closing 665 positions and reducing 2,392 holdings. Its most notable exit was iShares MSCI USA Min Vol Factor ETF, an estimated $13M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, up from 29% a quarter earlier, followed by Technology and Financials.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Core S&P 500 ETF worth $84M.

  • Tower Research Capital (TRC)'s largest Q2 2026 buy was iShares Core S&P 500 ETF: 112,156 shares worth $84M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $130M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2026 reduction was Direxion Daily Semiconductor Bull 3X ETF, cutting an estimated $361M.
  • Tower Research Capital (TRC) fully exited iShares MSCI USA Min Vol Factor ETF in Q2 2026, selling an estimated $13M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 19% of its $4.08B portfolio in Q2 2026.
  • Tower Research Capital (TRC) opened 764 new positions and closed 665 in Q2 2026.
  • Tower Research Capital (TRC)'s portfolio value rose 6.1% quarter-over-quarter to $4.08B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.